SOUTH ORANGE, NJ — Samikkannu Thangavel, the new associate director of the Institute of NeuroImmune Pharmacology at Seton Hall University, has received a five-year $2.2 million research award from the National Institutes of Health’s National Institute of Drug Abuse. The grant was awarded to Thangavel to conduct neuro-AIDS research in the context of drugs of […]
The post Institute of NeuroImmune Pharmacology at Seton Hall receives $2.2 million grant from NIH appeared first on Essex News Daily.